Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Fudan University Shanghai Cancer Center (Xiamen hospital), Shanghai, China.
Curr Neurovasc Res. 2024;21(1):101-109. doi: 10.2174/0115672026266627230921052416.
Obstructive sleep apnea (OSA) is one of the most common forms of sleep-disordered breathing. Studies have shown that certain changes in metabolism play an important role in the pathophysiology of OSA. However, the causal relationship between these metabolites and OSA remains unclear.
We use a mendelian randomization (MR) approach to investigate the causal associations between the genetic liability to metabolites and OSA.
We performed a 2-sample inverse-variance weighted mendelian randomization analysis to evaluate the causal effects of genetically determined 486 metabolites on OSA. Multiple sensitivity analyses were performed to assess pleiotropy. We used multivariate mendelian randomization analyses to assess confounding factors and mendelian randomization Bayesian model averaging to rank the significant biomarkers by their genetic evidence. We also conducted a metabolic pathway analysis to identify potential metabolic pathways.
We identified 14 known serum metabolites (8 risk factors and 6 protective factors) and 12 unknown serum metabolites associated with OSA. These 14 known metabolites included 8 lipids( 1-arachidonoylglycerophosphoethanolamine, Tetradecanedioate, Epiandrosteronesulfate, Acetylca Glycerol3-phosphate, 3-dehydrocarnitine, Margarate17:0, Docosapentaenoaten3;22:5n3), 3 Aminoacids (Isovalerylcarnitine,3-methyl-2-oxobutyrate,Methionine), 2 Cofactors and vitamins [Bilirubin(E,ZorZ,E),X-11593--O-methylascorbate], 1Carbohydrate(1,6-anhydroglucose). We also identified several metabolic pathways that involved in the pathogenesis of OSA.
MR (mendelian randomization) approach was performed to identify 6 protective factors and 12 risk factors for OSA in the present study. 3-Dehydrocarnitine was the most significant risk factors for OSA. Our study also confirmed several significant metabolic pathways that were involved in the pathogenesis of OSA. Valine, leucine and isoleucine biosynthesis metabolic pathways were the most significant metabolic pathways that were involved in the pathogenesis of OSA.
阻塞性睡眠呼吸暂停(OSA)是最常见的睡眠呼吸障碍之一。研究表明,代谢的某些变化在 OSA 的病理生理学中起着重要作用。然而,这些代谢物与 OSA 之间的因果关系尚不清楚。
我们使用孟德尔随机化(MR)方法研究代谢物遗传易感性与 OSA 之间的因果关系。
我们进行了两样本逆方差加权孟德尔随机化分析,以评估遗传决定的 486 种代谢物对 OSA 的因果影响。进行了多种敏感性分析以评估偏倚。我们使用多变量孟德尔随机化分析来评估混杂因素,并使用孟德尔随机化贝叶斯模型平均法对具有遗传证据的显著生物标志物进行排名。我们还进行了代谢途径分析以确定潜在的代谢途径。
我们确定了 14 种已知的血清代谢物(8 种风险因素和 6 种保护因素)和 12 种未知的血清代谢物与 OSA 相关。这 14 种已知代谢物包括 8 种脂质(1-花生四烯酰甘油磷酸乙醇胺、十四烷二酸、表雄甾酮硫酸盐、乙酰甘油 3-磷酸、3-脱氢肉碱、马尿酸 17:0、二十二碳五烯酸 3;22:5n3)、3 种氨基酸(异亮氨酸肉碱、3-甲基-2-氧代丁酸、蛋氨酸)、2 种辅因子和维生素[胆红素(E,Z 或 E,E)、X-11593--O-甲基抗坏血酸]、1 种碳水化合物(1,6-脱水葡萄糖)。我们还确定了几个涉及 OSA 发病机制的代谢途径。
本研究采用孟德尔随机化(MR)方法鉴定了 OSA 的 6 种保护因素和 12 种风险因素。3-脱氢肉碱是 OSA 的最显著危险因素。我们的研究还证实了几个涉及 OSA 发病机制的重要代谢途径。缬氨酸、亮氨酸和异亮氨酸生物合成代谢途径是涉及 OSA 发病机制的最重要的代谢途径。